• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Resolution of CMV Infection in the Bowel on Vedolizumab Therapy.

作者信息

Rawa-Gołębiewska Anna, Lenarcik Małgorzata, Zagórowicz Edyta

机构信息

Department of Oncological Gastroenterology, Maria Skłodowska-Curie Memorial Cancer Centre and Institute of Oncology.

Department of Gastroenterology, Hepatology and Clinical Oncology, Medical Centre for Postgraduate Education.

出版信息

J Crohns Colitis. 2019 Sep 19;13(9):1234-1235. doi: 10.1093/ecco-jcc/jjz033.

DOI:10.1093/ecco-jcc/jjz033
PMID:30860256
Abstract
摘要

相似文献

1
Resolution of CMV Infection in the Bowel on Vedolizumab Therapy.维多珠单抗治疗下肠道巨细胞病毒感染的消退
J Crohns Colitis. 2019 Sep 19;13(9):1234-1235. doi: 10.1093/ecco-jcc/jjz033.
2
[Cytomegalovirus infection in patients with ulcerative colitis].[溃疡性结肠炎患者的巨细胞病毒感染]
Eksp Klin Gastroenterol. 2010(10):25-8.
3
Using Vedolizumab to Treat Severe Sweet's Syndrome in a Patient With Ulcerative Colitis.使用维多珠单抗治疗一名溃疡性结肠炎患者的重症Sweet综合征。
J Crohns Colitis. 2018 Aug 29;12(9):1134-1135. doi: 10.1093/ecco-jcc/jjy066.
4
Successful Vedolizumab Therapy in a Sixteen-Year-Old Boy with Refractory Ulcerative Colitis.维多珠单抗成功治疗一名16岁难治性溃疡性结肠炎男孩。
J Crohns Colitis. 2016 Mar;10(3):373-4. doi: 10.1093/ecco-jcc/jjv205. Epub 2015 Nov 15.
5
Co-treatment With Golimumab and Vedolizumab to Treat Severe UC and Associated Spondyloarthropathy.戈利木单抗和维多珠单抗联合治疗重度溃疡性结肠炎及相关脊柱关节病
J Crohns Colitis. 2018 Feb 28;12(3):379-380. doi: 10.1093/ecco-jcc/jjx142.
6
Cytomegalovirus colitis complicating ulcerative colitis treated with adalimumab.巨细胞病毒性结肠炎并发溃疡性结肠炎，接受阿达木单抗治疗。
Scand J Gastroenterol. 2010 Apr;45(4):509-10. doi: 10.3109/00365520903583871.
7
Pharmacodynamic assessment of vedolizumab for the treatment of ulcerative colitis.维多珠单抗治疗溃疡性结肠炎的药效学评估。
Expert Opin Drug Metab Toxicol. 2016 Jul;12(7):833-42. doi: 10.1080/17425255.2016.1181171. Epub 2016 May 12.
8
Recurrent COVID-19 in a Patient With Ulcerative Colitis on Vedolizumab Therapy.接受维多珠单抗治疗的溃疡性结肠炎患者复发性新型冠状病毒肺炎
J Crohns Colitis. 2021 Jul 5;15(7):1244-1245. doi: 10.1093/ecco-jcc/jjaa259.
9
Response to vedolizumab for children with steroid-refractory Ulcerative Colitis unresponsive to anti-TNF.维多珠单抗对难治性溃疡性结肠炎儿童抗TNF治疗无效者的疗效。
Acta Paediatr. 2019 Jul;108(7):1359-1360. doi: 10.1111/apa.14765. Epub 2019 Mar 21.
10
Vedolizumab: a novel medical intervention in the treatment of primary sclerosing cholangitis.维多珠单抗：治疗原发性硬化性胆管炎的一种新型医学干预措施。
BMJ Case Rep. 2017 May 13;2017:bcr-2017-220351. doi: 10.1136/bcr-2017-220351.

引用本文的文献

1
Cytomegalovirus Colitis in Adult Patients with Inflammatory Bowel Disease.成人炎症性肠病患者的巨细胞病毒性结肠炎
Viruses. 2025 May 24;17(6):752. doi: 10.3390/v17060752.
2
Cytomegalovirus Infection in Adult Patients with Inflammatory Bowel Disease: A Literature Review.巨细胞病毒感染在炎症性肠病成年患者中的研究进展：文献综述。
Arch Iran Med. 2024 May 1;27(5):277-286. doi: 10.34172/aim.2024.40.
3
Cytomegalovirus Pneumonia in Inflammatory Bowel Disease: Literature Review and Clinical Recommendations.炎症性肠病中的巨细胞病毒肺炎：文献综述与临床建议
Infect Drug Resist. 2023 Sep 13;16:6195-6208. doi: 10.2147/IDR.S420244. eCollection 2023.
4
Ulcerative colitis successfully treated with vedolizumab in the presence of comorbid opportunistic infections: a case report.伴有合并机会性感染的溃疡性结肠炎经维得利珠单抗成功治疗：一例报告。
J Med Case Rep. 2023 May 31;17(1):227. doi: 10.1186/s13256-023-03940-y.
5
Cytomegalovirus Colitis in a Patient With Ulcerative Colitis on Vedolizumab Monotherapy.接受维多珠单抗单药治疗的溃疡性结肠炎患者发生巨细胞病毒性结肠炎
Cureus. 2023 Feb 25;15(2):e35473. doi: 10.7759/cureus.35473. eCollection 2023 Feb.
6
Cytomegalovirus and Inflammatory Bowel Diseases (IBD) with a Special Focus on the Link with Ulcerative Colitis (UC).巨细胞病毒与炎症性肠病（IBD），特别关注与溃疡性结肠炎（UC）的关联。
Microorganisms. 2020 Jul 20;8(7):1078. doi: 10.3390/microorganisms8071078.
7
Safe and Successful Treatment of Acute Cellular Rejection of an Intestine and Abdominal Wall Transplant With Vedolizumab.维多珠单抗安全成功治疗肠道和腹壁移植的急性细胞排斥反应
Transplant Direct. 2020 Jan 17;6(2):e527. doi: 10.1097/TXD.0000000000000973. eCollection 2020 Feb.